D. Risso

发表

13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease.

Paolo Borro, Alessandra Fumagalli, R. Testa, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Colour blindness in everyday life and car driving.

A. Piro, A. Tagarelli, G. Tagarelli, 2004, Acta ophthalmologica Scandinavica.

Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit.

C. Bellini, G. Serra, D. Risso, 2007, Clinical chemistry and laboratory medicine.

Effects of reduced glutathione and n‐acetylcysteine on lidocaine metabolism in cimetidine treated rats

R. Testa, E. Giannini, M. Ghia, 1998, Fundamental & clinical pharmacology.

Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.

R. Testa, A. Fasoli, E. Giannini, 2001, Digestive diseases and sciences.

Increased Levels of γGT Suggest the Presence of Bile Duct Lesions in Patients with Chronic Hepatitis C

R. Testa, A. Fasoli, E. Giannini, 2001, Digestive Diseases and Sciences.

Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis

R. Testa, A. Fasoli, E. Giannini, 2003, Gut.

Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20‐year period: a multicentre Italian study

M. Zoli, E. Giannini, F. Farinati, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens

R. Testa, A. Fasoli, E. Giannini, 2000, American Journal of Gastroenterology.

Influence of age on clinical presentation, therapeutic options, and prognosis in anti-HCV positive cirrhotic patients with hepatocellular carcinoma.

R. Testa, A. Fasoli, E. Giannini, 2002, Age and ageing.

Utility of alpha-glutathione S-transferase assessment in chronic hepatitis C patients with near normal alanine aminotransferase levels.

R. Testa, A. Fasoli, E. Giannini, 2000, Clinical biochemistry.

Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C

R. Testa, E. Giannini, E. Giannini, 2001, European journal of gastroenterology & hepatology.

Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients

R. Testa, E. Giannini, D. Risso, 2001, American Journal of Gastroenterology.

Transarterial chemoembolization in Child–Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea

M. Zoli, E. Giannini, F. Farinati, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Prognosis of hepatocellular carcinoma in anti‐HCV positive cirrhotic patients: a single‐centre comparison amongst four different staging systems

R. Testa, E. Giannini, F. Botta, 2004, Journal of internal medicine.

Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients.

R. Testa, A. Fasoli, E. Giannini, 1999, Liver.

Perineal ultrasound evaluation of the urethrovesical junction angle and urethral mobility in nulliparous women and women following vaginal delivery

F. Esposito, D. Risso, P. Lantieri, 2005, International Urogynecology Journal.

Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?

R. Testa, A. Fasoli, E. Giannini, 2000, Hepato-gastroenterology.

The monoethylglycinexylidide test does not impair psychometric performance in patients with chronic hepatitis or cirrhosis.

R. Testa, A. Fasoli, E. Giannini, 2000, Therapeutic drug monitoring.

Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus‐positive patients

R. Testa, A. Fasoli, F. Ansaldi, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Comparison of Central Corneal Thickness Measurements Using Ultrasonic Pachymetry, Anterior Segment OCT and Noncontact Specular Microscopy

M. Papadia, C. Traverso, A. Bagnis, 2017, Journal of glaucoma.

Cholestasis is the Main Determinant of Abnormal CA 19–9 Levels in Patients with Liver Cirrhosis

R. Testa, A. Fasoli, E. Giannini, 2000, The International journal of biological markers.

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis

R. Testa, E. Giannini, F. Botta, 2002, American Journal of Gastroenterology.

Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and α-glutathione S-transferase levels

R. Testa, A. Fasoli, G. Icardi, 2001, European journal of gastroenterology & hepatology.

Impact of evidence‐based medicine on the treatment of patients with unresectable hepatocellular carcinoma

M. Zoli, E. Giannini, F. Farinati, 2010, Alimentary pharmacology & therapeutics.

Transvaginal sonohysterographic evaluation of uterine malformations.

N. Ragni, D. Risso, P. Lantieri, 2006, European journal of obstetrics, gynecology, and reproductive biology.

MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study

E Testa, R. Testa, A. Fasoli, 2003, Gut.

Grading of laboratories on CD4+ T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error.

B. Brando, M. Girotto, L. Mortara, 2002, Cytometry.

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.

R. Testa, A. Fasoli, E. Giannini, 2003, Archives of internal medicine.

Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis

E Testa, R. Testa, A. Fasoli, 2003, Gut.

Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.

R. Testa, M. Zoli, E. Giannini, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Maternal dietary PUFAs intake and human milk content relationships during the first month of lactation.

W. Bonacci, D. Risso, P. Lantieri, 2001, Clinical nutrition.

Fatty acid composition of human milk in Italy.

W. Bonacci, A. Marletta, D. Risso, 1997, Biology of the neonate.

Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index.

R. Testa, E. Giannini, L. Isola, 2006, Journal of internal medicine.

The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.

R. Testa, E. Giannini, F. Botta, 2002 .

Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients.

R. Testa, E. Giannini, D. Risso, 2001 .

Progressive Liver Functional Impairment Is Associated with an Increase in AST/ALT Ratio

R. Testa, A. Fasoli, E. Giannini, 1999, Digestive Diseases and Sciences.